Interestingly, nuclear localisation of B7-H3 strongly predicted poor outcome in colon cancer, suggesting that nuclear B7-H3 might be considered a new biomarker that could facilitate colon cancer treatment decisions, pending validation of the results in other CRC cohorts. The gene discussed is CD276; the disease is colonic neoplasm.